Sharing Trial Data

It is time that drug companies get with the program and accept that sharing of clinical trials data is a good thing, and should be more widely adopted, at the very least because it could engender more trust between pharmaceutical companies and patients, Nature writes in an editorial.

The comments were published on the heels of a new UK government report which said that drug makers have been routinely hiding clinical trial information from researchers and doctors.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.